Virtual Meetings

Without a doubt, [1-13]pyruvate is the hyperpolarized MRI gold standard, and it holds great potential in the clinic in terms of accurate diagnostic and treatment monitoring for conditions ranging from cancer to neurodegenerative and cardiovascular disease. Nonetheless, during the past few years great progress has been made in developing novel probes to investigate different metabolic pathways and organ perfusion. Our speakers will talk about "hyperpolarized MRI beyond pyruvate" using both dDNP and PHIP techniques. Particular attention will be given to development of hyperpolarized glycine at pre-clinical level and clinical translation of hyperpolarized [¹³C,¹⁵N₂]urea for human brain perfusion studies. The event will highlight cutting-edge innovations driving the future of molecular imaging and metabolic characterization.

The RF System Tutorial session brings together three complementary lectures, providing participants with a comprehensive overview of RF engineering across field strengths. “From Low to Ultra-High Field: Engineering Considerations for RF Coils” explores the practical challenges and solutions in coil design at different operating regimes. “Tutorial on Preamplifier Design & Characterization” offers insights into optimizing signal performance and stability. Finally, “RF Coils, Preamps & Filters: Design Across Field Strengths” connects these topics, illustrating how integrated design strategies ensure robust performance from low- to ultra-high field MRI applications.

Emerging technologies in neuromodulation, such as transcutaneous vagus nerve stimulation (tVNS) and photobiomodulation, are opening new frontiers for both clinical and research applications. These non-invasive approaches offer safer, more accessible alternatives to traditional brain stimulation techniques, reducing risks associated with surgery or implanted devices while broadening opportunities for patient populations. tVNS shows considerable promise in regulating autonomic function, mood, and inflammatory processes, whereas photobiomodulation leverages light to enhance mitochondrial activity, cellular metabolism, and neuroplasticity. Importantly, when combined with advanced MRI methodologies—including functional MRI, spectroscopy, and connectivity mapping—these techniques allow researchers to quantify neural dynamics and metabolic responses in vivo. This integration provides objective biomarkers of efficacy and mechanistic insight, supporting rigorous evaluation of novel protocols. Their adaptability, portability, and compatibility with neuroimaging platforms further strengthen their role in advancing precision neuromodulation and accelerating translation into personalized therapeutic strategies with potential for widespread clinical integration.

Do you feel you lack the big-picture insight into the different cardiac MRI methods and how they are applied clinically?

Join this trainee-initiated webinar (open to everyone) designed to unravel the complexities of clinical cardiac MRI and bridge the gap between research innovations and clinical applications. The session will provide an overview of the different types of cardiac MRI images used in clinical practice, outlining what parameters and qualitative assessments are derived from each modality, the specific clinical questions these assessments address, and how their answers can directly influence a patient’s future care and management decisions. We will also highlight the current weaknesses and limitations of these techniques and discuss what the research community could do to overcome them. In addition, we will explore emerging and innovative methods in cardiac MRI research and how they could address unmet clinical needs, improve diagnostic accuracy, and open new avenues for treatment planning. This is an excellent opportunity to gain both breadth and depth of insight into the role of cardiac MRI in cardiovascular medicine.

Join us for this ISMRM virtual meeting exploring how to build impactful collaborations in MRI research between academia and pharma, which will be of broad interest across subspecialty areas. Hear directly from Rob Janiczek, Ph.D., on what pharma looks for in partnerships, followed by academic perspectives from Grace Parraga, Ph.D., FCAHS, on investigator-sponsored research for lung indications and Tammie Benzinger, M.D., Ph.D., on industry-sponsored research for neuro indications.

This virtual meeting of the ISMRM Low-Field MRI Study Group will focus on opportunities and barriers to low-field MRI clinical adoption. The goal is to help our membership understand how low-field MRI can make a tangible impact in clinical care. Through four short, clinician-led presentations (7 minutes each)—spanning brain, musculoskeletal, breast, and low-resource settings—participants will hear real-world experiences, success stories, and lessons learned about implementation and challenges. A 30-minute moderated discussion will follow, highlighting the most critical barriers and priorities for future research. The session aims to bridge the gap between technical innovation and clinical translation, fostering a community-wide understanding of how low-field MRI can be adopted to improve patient care and expand access to imaging.

This webinar highlights the use of perfusion imaging in clinical studies, encompassing past experiences, technical considerations, and currently ongoing clinical trials with special focus on potential future clinical trials using ASL.

This one-hour virtual meeting presents an overview of current deep learning reconstruction methods in the field of magnetic resonance electrical properties tomography (MR-EPT) and quantitative susceptibility mapping (QSM). It also aims at presenting the most recent guidelines on MR-EPT acquisitions, phantom preparation, and standardization of reporting, following the recent MR-EPT reconstruction challenge. Finally, it gives the opportunity to inform the study group about ongoing and new initiatives as well as to new candidates for the open positions within the EMTP study group committee to present themselves.